Following a meeting in Washington with representatives of the U.S. Department of Commerce, the Minister of Finance, Alexandru Nazare, announced the interest of American investors in strategic areas in Romania, such as infrastructure and health.
Raluca Ioana Draghici
.webp)
Economy
www.shutterstock.com
Always see our news on Google
During a meeting in Washington with representatives of the U.S. Department of Commerce, Finance Minister Alexandru Nazare emphasized the interest of American investors in areas such as infrastructure, energy, technology, and health. This meeting marks the resumption of official dialogue with the U.S. and the opening towards new investments. Nazare mentioned that, in the next three months, the Department of Commerce will organize events in Bucharest to support attracting capital and expertise in public-private partnership projects in Romania.
Sources
Ministrul Finanțelor, după întâlnirea la Washington cu reprezentanţii Departamentului de Comerţ al SUA: Interesul american se concentrează asupra unor domenii strategice: infrastructură, energie, tehnologie, sănătate
În ce domenii vor să investească americanii în România. Anunțul ministrului Finanțelor după întâlnirile de la Washington
Ministrul Alexandru Nazare afirmă că interesul american se concentrează asupra unor domenii strategice: infrastructură, energie, tehnologie și sănătate
Latest News
08:06
The U.S. Treasury debt has reached $40.047 trillion, exceeding CBO estimates. The rapid increase in the deficit raises concerns in the financial markets.
07:59
The Washington Post: Russians withdraw billions from banks, fearing that Putin will confiscate their deposits to finance his war
07:46
Hungary: The construction of a riverbed threshold on the Danube has raised the water level by 15-20 cm, preventing the shutdown of the turbines at the Paks nuclear power plant.
07:45
Kiev was the target of a new attack with Russian ballistic missiles. At least six people have died and 12 have been injured.
07:37
An experimental cancer vaccine, developed by Moderna and Merck, has shown promising results in patients with melanoma.
See more news
NEWS ON THE SAME TOPICS
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
